Last reviewed · How we verify

NCT06211816

Efficacy of End-of-life Communication Strategies on Nurses in the Intensive Care Unit

Completed NA Last updated 18 January 2024
What this trial tests

NA trial testing communication strategy in Palliative Care in 69 participants. Completed in 1 December 2023.

Timeline
1 September 2022
Primary endpoint
1 November 2023
1 December 2023

Quick facts

Lead sponsorMaebashi Red Cross Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment69
Start date1 September 2022
Primary completion1 November 2023
Estimated completion1 December 2023
Sites1 location across Japan

Drugs / interventions tested

Conditions studied

Sponsor

Maebashi Red Cross Hospital

Who can join

Eligibility, any sex, with Palliative Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Burnout among healthcare workers is frequently reported, and one of the factors cited is the stress caused by end-of-life care. It has been reported that nursing staff experience decreased well-being as a result of being involved in end-of-life care, and this is also true in intensive care units. This decrease in well-being is said to lead to lower quality of care, poor communication with patients and their families, absenteeism, and high turnover. Although palliative care interventions such as education and communication tools have been reported to improve the well-being of healthcare professionals involved in end-of-life care, few reports have evaluated the association with burnout. We investigated whether communication-based palliative interventions in end-of-life care in intensive care units (ICUs) improve the risk of burnout among nurses working in ICUs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Palliative Care

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06211816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing